As a leading global pharmaceutical company, Pfizer entrusts its talented research and development team to the monumental task of discovering and developing innovative, safe, and effective ways to prevent or treat some of the world's most challenging diseases. We are committed to invest and partner with industry and academia to find new cures to various diseases.
We are committed to the safety of patients who take part in our trials, uphold the highest ethical standards in all of our research initiatives and to build the world's premier biopharmaceutical R&D organization. Together, our aspirations are to deliver unparalleled innovation, the best internal and external science, and industry leading productivity within a vibrant, diverse culture.
Pfizer now has broader and deeper disease area knowledge in our Research Units, increased modality and technology capabilities in our Biotechnology Units, and a new approach that harnesses our combined strengths to find the newest, most innovative, and valuable medical solutions. Pfizer possesses the scale, portfolio, talent, and capabilities that we believe will unlock new levels of productivity. Drug discovery requires both disease area and technology expertise. Our new model has the breadth and depth of Research Units and Biotechnology Units across R&D that frees us to realize the power and possibilities of these combinations to deliver high impact medicines for patients.
Pfizer is a pharmaceutical company with a strong pedigree in medical research and the development of new drugs. Since our journey began in 1849, we have always been committed to finding innovations that help people. Our research and development team has helped the world discover some of the most important medicines to date. Our innovations have helped treat and prevent diseases for millions of patients in Hong Kong and the rest of the world.
Many of today’s most important medicines and drugs find their roots in Pfizer’s research and development efforts.
During the global pandemic, Pfizer’s medicines and vaccines have reached an estimated 1.4 billion patients in 2021. Alongside other leading pharmaceutical companies and the larger science and medical community, Pfizer has played a crucial role in the research and development of COVID-19 vaccines, and led the combat against one of the largest pandemics in history. With 25,000 clinical researchers testing every day and cutting-edge innovations, our science holds the cure.
For further information of our research projects, please visit:
www.pfizer.com/research